Systemic Juvenile Idiopathic Arthritis (SJIA)-Pipeline Insights, 2016


#516219

60pages

DelveInsight

$ 1250

In Stock

SUMMARY
DelveInsights, Systemic Juvenile Idiopathic Arthritis (SJIA)-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Systemic Juvenile Idiopathic Arthritis (SJIA). The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Systemic Juvenile Idiopathic Arthritis (SJIA). DelveInsights Report also assesses the Systemic Juvenile Idiopathic Arthritis (SJIA) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope